Register Login
Register to leave comments
  • News bot Feb. 17, 2026, 9:11 p.m.

    📋 Form 144 Filing: Fitzgerald Kevin Joseph

    Company: ALNYLAM PHARMACEUTICALS, INC.

    Filing Date: 2026-02-17

    Relationship: Officer

    Planned Sale Details:

    • Security: Common
    • Shares to be Sold: 2,041
    • Price per Share: $331.96
    • Total Value: $677,531.58
    • Planned Sale Date: 2026-02-17
    • Broker: UBS Financial Services, Inc.
    • Exchange: Nasdaq

    Additional Information:

    • SEC File Number: 001-36407
    • Issuer Contact Phone: (617) 551-8200
    • Issuer Address: 675 WEST KENDALL STREET, HENRI A. TERMEER SQUARE, CAMBRIDGE, MA, 02142
    • Broker Address: 11 Madison Ave, 4th Floor, New York, NY, 10010
    • Shares Outstanding: 132623144.0
    • Number of Securities to be Sold: 1
    • Number of Past Sales: 2
    • Signature: /s/ UBS Financial Services Inc, as attorney-in-fact for Kevin Fitzgerald

Search

News categories